Which Treatment Leads to Better UC Clinical Responses: Upadacitinib or Ustekinumab?
source: pixabay.com

Which Treatment Leads to Better UC Clinical Responses: Upadacitinib or Ustekinumab?

During the ACG Annual Scientific Meeting, which took place this year from October 20 through 25, one presenter shared insights into a multicenter retrospective cohort study which explored the efficacy…

Continue Reading Which Treatment Leads to Better UC Clinical Responses: Upadacitinib or Ustekinumab?

Zika Virus Could Stop Prostate Cancer Spread, Study Shows – But It Has a Dangerous Side Effect

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading Zika Virus Could Stop Prostate Cancer Spread, Study Shows – But It Has a Dangerous Side Effect
Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
source: pixabay.com

Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)

As shared by MedScape, the U.S. FDA recently approved the first treatment for people living with congenital thrombotic thrombocytopenic purpura (TTP). Its name? Adzynma. In the past, people with TTP…

Continue Reading Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
Phase III Trial meets Primary Endpoint for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
source: pixabay.com

Phase III Trial meets Primary Endpoint for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)

  Patients with severe asthma with an eosinophilic phenotype who are 12 years of age or older may now receive treatment with FASENRA as an add-on maintenance treatment. Note that…

Continue Reading Phase III Trial meets Primary Endpoint for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
NFL Player Foster Moreau is in Full Remission from Hodgkin’s Lymphoma
https://pixabay.com/en/american-football-football-sports-1666276/

NFL Player Foster Moreau is in Full Remission from Hodgkin’s Lymphoma

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading NFL Player Foster Moreau is in Full Remission from Hodgkin’s Lymphoma
Living with Pulmonary Fibrosis: Adam’s Rare Patient Story (and World Record Attempt!)
source: shutterstock.com

Living with Pulmonary Fibrosis: Adam’s Rare Patient Story (and World Record Attempt!)

Written by Adam Faatz Imagine not being able to breathe and spending nine days climbing the world's tallest freestanding mountain. That is my story, and that is my goal. Sixty-five…

Continue Reading Living with Pulmonary Fibrosis: Adam’s Rare Patient Story (and World Record Attempt!)
New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
source: shutterstock.com

New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog

We are excited to announce that Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is…

Continue Reading New Podcast Episode: Going All In On Support, feat. Patient Advocates Kathi and Dave Herzog
Vamorolone Has Been FDA Approved to Treat Duchenne Muscular Dystrophy
Source: https://unsplash.com/photos/ZHys6xN7sUE

Vamorolone Has Been FDA Approved to Treat Duchenne Muscular Dystrophy

Vamorolone, now marketed as AGAMREE®, is termed a dissociative steroid therapy, as it has proven its potential to retain the muscle-strengthening and anti-inflammatory benefits of corticosteroids. On the other side…

Continue Reading Vamorolone Has Been FDA Approved to Treat Duchenne Muscular Dystrophy
Mom Signed Up Thousands of Stem Cell Donors in Support of Son with IPEX
source: shutterstock.com

Mom Signed Up Thousands of Stem Cell Donors in Support of Son with IPEX

  Every three to four minutes, someone in the U.S. is diagnosed with a blood disease such as lymphoma, leukemia, or sickle cell anemia. As reported in the Pittsburgh Post-Gazette,…

Continue Reading Mom Signed Up Thousands of Stem Cell Donors in Support of Son with IPEX

Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%

The words ‘vigorous exercise’ usually bring to mind running marathons or playing pickleball. Inside Precision Medicine reports that researchers at a Sydney, Australia University tracked the daily activity of more…

Continue Reading Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%

Wealthy Facioscapulohumeral Muscular Dystrophy Patient Invests $100 Million to Find a Cure  

  Chip Wilson, billionaire founder of Lululemon Athletica, was first diagnosed with muscular dystrophy in 1987 at the age of 32. Wilson, who is now 66 years old told Global…

Continue Reading Wealthy Facioscapulohumeral Muscular Dystrophy Patient Invests $100 Million to Find a Cure  
Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis
source: pixabay.com

Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis

Give the gift of life this holiday season and consider donating your bone marrow to BeTheMatch. Each year, over 18,000 people are diagnosed with a life-threatening blood condition that could…

Continue Reading Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis